Pay in 4 interest-free payments of $5.75 Learn more
Ships within 48 hours · Estimated delivery Nov 7 - Nov 12
Where the original GLOW blend combined three peptides for tissue regeneration and collagen production, KLOW adds a fourth component that fundamentally changes what the stack can do
Worked better than expectations*
Despite the lack of meal dependency at the injection level, the GLP-1 and GIP receptor components of retatrutide do interact meaningfully with postprandial physiology
A separate human study measured endogenous DSIP across normal subjects and patients with sleep apnea and narcolepsy, treating the compound as an endogenous marker rather than a confirmed therapeutic (PMID 8532601)
Here are a few key studies that highlight the peptides potential: BPC 157 is an exciting and versatile peptide with a range of therapeutic benefits
